These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7464118)

  • 1. Inhibition of androgen aromatization in human breast cancer.
    Abul-Hajj YJ
    J Steroid Biochem; 1980 Dec; 13(12):1395-400. PubMed ID: 7464118
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
    Kellis JT; Vickery LE
    Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effects of aminoglutethimide, testololactone, and 4-hydroxyandrostenedione as inhibitors of aromatase.
    Santner SJ; Rosen H; Osawa Y; Santen RJ
    J Steroid Biochem; 1984 Jun; 20(6A):1239-42. PubMed ID: 6748639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of estrogen synthesis in human breast tumors by testololactone and bromoandrostenedione.
    Budnick RM; Dao TL
    Steroids; 1980 May; 35(5):533-41. PubMed ID: 7394858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
    Abul-Hajj YJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3373s-3377s. PubMed ID: 6211227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanism of action of the aromatase inhibitor, 4-hydroxyandrostenedione.
    Abul-Hajj YJ
    Steroids; 1983 Jun; 41(6):783-90. PubMed ID: 6665821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis.
    Brueggemeier RW; Floyd EE; Counsell RE
    J Med Chem; 1978 Oct; 21(10):1007-11. PubMed ID: 722711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.
    Dowsett M; Santner SJ; Santen RJ; Jeffcoate SL; Smith IE
    Br J Cancer; 1985 Jul; 52(1):31-5. PubMed ID: 4015950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen synthesis in human breast tumor and its inhibition by testololactone and bromoandrostenedione.
    Dao TL
    Cancer Res; 1982 Aug; 42(8 Suppl):3338s-3341s. PubMed ID: 7083197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active-site-directed inactivation of aromatase from human placental microsomes by brominated androgen derivatives.
    Bellino FL; Gilani SS; Eng SS; Osawa Y; Duax WL
    Biochemistry; 1976 Oct; 15(21):4730-6. PubMed ID: 974087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective inhibition of aromatase by enantiomers of aminoglutethimide.
    Graves PE; Salhanick HA
    Endocrinology; 1979 Jul; 105(1):52-7. PubMed ID: 446416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic analysis of reversible inhibition of 16alpha-hydroxyandrostenedione aromatization in human placental microsomes by suicide substrates of androstenedione aromatization.
    Numazawa M; Mutsumi A; Tachibana M; Yoshimura A
    Biol Pharm Bull; 2003 Jun; 26(6):890-2. PubMed ID: 12808307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition and inactivation of estrogen synthetase (aromatase) by fluorinated substrate analogues.
    Marcotte PA; Robinson CH
    Biochemistry; 1982 May; 21(11):2773-8. PubMed ID: 7093221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of the direct aromatization of testosterone and different aromatization sites for testosterone and androstenedione in human placental microsomes.
    Bellino FL; Osawa Y
    Biochemistry; 1974 Apr; 13(9):1925-31. PubMed ID: 4152129
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
    MacIndoe JH; Woods GR; Etre LA; Covey DF
    Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative interaction of reduced pyridine nucleotides with estrogen synthetase of human placental microsomes.
    Milewich L; Hendricks TS; Masters BS; Frenkel RA; MacDonald PC
    Arch Biochem Biophys; 1981 Oct; 211(2):530-6. PubMed ID: 7305387
    [No Abstract]   [Full Text] [Related]  

  • 17. The flux of intermediates and products in aromatizaton of C19 steroids by human placental microsomes.
    Braselton WE; Engel LL; Orr JC
    Eur J Biochem; 1974 Oct; 48(1):35-43. PubMed ID: 4155685
    [No Abstract]   [Full Text] [Related]  

  • 18. Overview of recent development of aromatase inhibitors.
    Brodie AM
    Cancer Res; 1982 Aug; 42(8 Suppl):3312s-3314s. PubMed ID: 7083192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent aromatase inactivation by 4 beta,5 beta-epoxides of the natural substrate androstenedione and its 19-oxygenated analogs.
    Numazawa M; Yoshimura A; Tachibana M; Shelangouski M; Ishikawa M
    Steroids; 2002 Mar; 67(3-4):185-93. PubMed ID: 11856542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
    Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD
    J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.